Armata Pharmaceuticals, Inc. — Director's Dealing 2005

Aug 2, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-07-29

Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-07-29	Common Stock, $0.01 Par Value	S	8000	$0.80	Disposed	11857448	Indirect
2005-08-01	Common Stock, $0.01 Par Value	S	9300	$0.77	Disposed	11848148	Indirect
2005-08-01	Common Stock, $0.01 Par Value	S	2200	$0.7702	Disposed	11845948	Indirect
2005-08-01	Common Stock, $0.01 Par Value	S	600	$0.7703	Disposed	11845348	Indirect
2005-08-01	Common Stock, $0.01 Par Value	S	3400	$0.7704	Disposed	11841948	Indirect
2005-08-01	Common Stock, $0.01 Par Value	S	7300	$0.78	Disposed	11834648	Indirect
2005-08-01	Common Stock, $0.01 Par Value	S	2200	$0.80	Disposed	11832448	Indirect

Footnotes

F1: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.